Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00970086Phase 4
Key facts
Phase 4, randomised trial of levobupivacaine in postoperative pain (2 arms), sponsored by University Hospital Basel. Primary endpoint: Efficacy of the postoperative analgesia at 1 day. Started Aug 2009; status: terminated.
TAP Block
Ultrasound-guided Transversus Abdominis Plane block with Levobupivacaine
Caudal Block
Standard Caudal block with Bupivacaine
Efficacy of the postoperative analgesia
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00970086.